Steven Cohen's TNGX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 533,937 shares of Tango Therapeutics, Inc. (TNGX) worth $11.17 M, representing 0.01% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 7 quarters.
Based on 13F filings, Steven Cohen has maintained this position in TNGX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 2.92 M shares. Largest reduction occurred in Q1 2026, reducing 1.44 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Tango Therapeutics (TNGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tango Therapeutics (TNGX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -1.44 M | Reduce 72.95% | 533,937 | $20.92 |
| Q4 2025 | -945,415 | Reduce 32.38% | 1.97 M | $8.86 |
| Q3 2025 | +2.92 M | New Buy | 2.92 M | $8.40 |
| Q3 2024 | -447,107 | Sold Out | 0 | $0.00 |
| Q2 2024 | +447,107 | New Buy | 447,107 | $8.58 |
| Q2 2023 | -7,346 | Sold Out | 0 | $0.00 |
| Q1 2023 | +7,346 | New Buy | 7,346 | $3.95 |
Steven Cohen's Tango Therapeutics Investment FAQs
Steven Cohen first purchased Tango Therapeutics, Inc. (TNGX) in Q1 2023, acquiring 7,346 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Tango Therapeutics, Inc. (TNGX) for 7 quarters since Q1 2023.
Steven Cohen's largest addition to Tango Therapeutics, Inc. (TNGX) was in Q3 2025, adding 2,919,450 shares worth $24.52 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 533,937 shares of Tango Therapeutics, Inc. (TNGX), valued at approximately $11.17 M.
As of the Q1 2026 filing, Tango Therapeutics, Inc. (TNGX) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Tango Therapeutics, Inc. (TNGX) was 2,919,450 shares, as reported at the end of Q3 2025.